• 제목/요약/키워드: JIJU(積聚)

검색결과 4건 처리시간 0.216초

적취(積聚)를 위주로 한 종양(腫瘍)의 치법(治法)에 관한 소고(小考) (Brief review of cancer treatment focused on JIJU(積聚))

  • 박재현;문구
    • 대한암한의학회지
    • /
    • 제13권1호
    • /
    • pp.1-11
    • /
    • 2008
  • Objectives: To grasp the traditional stream of cancer treatment inherited from the previous doctors. Methods: The author's research has been performed cancer treatment based on JIJU(積聚) taking the original text as a reference. Results & Conclusion: The general three outlines and five detailed rules of cancer treatment have been obtained as follows. The first outline of cancer treatment is that reinforced vital function makes cancer reduce naturally. the second is that Harmless cancer can coexist in human beings and aging with them. and the third is that Elimination and reinforcing therapies should be executed in appropriate era and those therapies should utilize appropriate methods. The first detailed rule of cancer treatment is when using reinforcing therapy, it must applicate mildly and when using elimination therapy, it must applicate calmly. The second detailed rule is that the methods of cancer treatment are different from each cancer stage. The concentration should be made on reinforcing therapy at early stage while reinforcing and elimination therapies must be conducted together at middle stage. At terminal stage reinforcing therapy is the sole method to be taken. The third detailed rule is that the basis property of cancer drug is warm nature and extremely biased property should be avoided and when complication arises (eg. inflamatory disease, cancer fever, etc), cold or cool nature can be applied. The fourth detailed rule is that Cancer drug must have the effect eliminating the blood stasis, phlegm and excessive fluid, all together. The fifth detailed rule is that Physicians have to control patient's stress or stress related symptom and teach patients about right way of taking care of themselves and patients should take hygienic rules with their free will by themselves (eg diet, exercise, stress, etc)

  • PDF

고창(鼓脹)의 처방(處方)에 대한 문헌적(文獻的) 고찰(考察)

  • 이용운;김일렬;최창원;이강녕;이영수;곽정진;김희철
    • 대한한의학방제학회지
    • /
    • 제9권1호
    • /
    • pp.165-206
    • /
    • 2001
  • After this study, I report the following result from it 1. 'Qiao zhang' is the symptoms that the abdomen is distension and fullness, but face, eye, four limb is not dropsial swelling. It corresponds to the Gu zhang(?脹), Zhang man(脹滿), Jiju(積聚), Dan fu zhang(單腹脹), Zhong man(重滿) of the Oriental Medicine. 2. The cause and overeating and, and malfunction pathology of the 'Qiao zhang' were accumulation of water cause of overeating and, overdrinking, the hurt of feeling, overwork, infection of blood sucker and malfunction of liver, spleen and kidney for jandice and Jiji(積聚) 3. The treatment of the 'Qiao zhang' was reinforcing middle-energizer and replenishing Qi and allevating water retention because middle-energizer were much weak. 4. The prescription of the 'Qiao zhang' that Zhang man fen xiao wan(中滿分消散) were 16 times the most. Zhang man fen xiao tang(中滿分消湯), Guang man kui jian tang(廣茂潰堅湯), ren shen gui pi tang(人蔘芎歸湯), Yu yu liang wan(禹餘糧丸), mun xiang sun qi tang(木香順氣散) were next. 5. The single herb of the prescription of the 'Qiao zhang' that were Auckrandiae Radix(木香), Citri Pericarpium(陳皮) for rephenshing qi drug, Atractylodis Macrocephalae Phieoma(白朮), Ginseng Radix(人蔘), Magnoliae Cortex(厚朴) for regurating qi drug, Pinelliae Rhzoma(半夏) for dischanging phlegm drug.

  • PDF

한국표준질병사인분류(KCD)에 오적(五積) 추가에 대한 제안 (A Proposal on the Addition of Wǔjī(五積) in KCD(Korean standard classification of disease and cause of death))

  • 이재흥;노주희;강한주;배재룡
    • 대한의료기공학회지
    • /
    • 제19권1호
    • /
    • pp.43-98
    • /
    • 2019
  • Objective : The purpose of this study is to propose adding Wǔjī(五積) to KCD. Methods : The pathological details of Wǔjī(五積) mentioned in the classic literatures were extracted and compiled to provide the basis that Wǔjī(五積) should be registered in the KCD. Conclusions : 1. Jī(積) is a very important pathological and clinically element of Korean Medicine. So not only Shíjī(食積) but also Wǔjī(五積) should be registered in the KCD. 2. We suggest adding Wǔjī((五積) to the U-Code 64~71 of the KCD due to its pathological nature. 3. If Wǔjī((五積) is registered in the KCD, it will provide a more systematic and objective approach to Jī(積) in the future, and it is expected to provide an opportunity to drastically enhance the performance of Korean Medicine treatments for cancer or tumors by forming various and extensive big data. 4. Regardless of whether or not Wǔjī((五積) is added to the KCD, the clinical and pathological re-establishment of Wǔjī(五積) should be performed in accordance with the present period and social situation through continuous and extensive clinical research about Jī(積).